Tuesday, April 22, 2025

Yearly Archives: 2020

Introduction to medical writing

Medical writing is the making of scientific documents by the specialized writers. Generally a medical writer closely works with scientists, doctors and other subject matter experts...

Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer

April 24, 2020: AstraZeneca and MSD Inc. announced further positive results from the Phase III PROfound trial of Lynparza (olaparib) in men with metastatic castration-resistant...

HHS Announces CARES Act Funding Distribution to States and Localities in Support of COVID-19 Response

April 23, 2020: "The Department of Health and Human Services (HHS) is announcing upcoming action by the Centers for Disease Control and Prevention...

Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19

April 23, 2020: "For patients hospitalized with mild/moderate COVID-19, lopinavir/ritonavir (LPV/r) or umifenovir (Arbidol) monotherapy offers little benefit, according to a study published online...

Novartis announces data showing Jakavi® (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease

Apr 22, 2020: "Data from the Phase III REACH2 study published today in The New England Journal of Medicine show Jakavi® (ruxolitinib) improves outcomes across a...

AstraZeneca and Saint Luke’s Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients

April 23, 2020: "AstraZeneca and Saint Luke’s Mid America Heart Institute have initiated a randomised, global Phase III trial to assess the potential of Farxiga (dapagliflozin)...

WHO reports fivefold increase in cyber attacks, urges vigilance

April 23, 2020: "Since the start of the COVID-19 pandemic, the World Health Organization has seen a dramatic increase in the number of cyber...

TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test

April 22, 2020: TearLab Corporation announced that the U.S.FDA has accepted the resubmission of its 510(k) application for the potential clearance of its TearLab...

Michigan AG Nessel Leads Coalition in Asking Congress to Regulate Prices of Medical Supplies, Equipment During COVID-19 Pandemic

April 23, 2020: Michigan Attorney General Dana Nessel is leading a coalition of attorneys general from across the country in sending a letter today to Congress asking lawmakers...

Attorney General Nessel Sends Letter Urging FDA to Base Blood Donation Restrictions on Risk, Not Sexual Orientation

April 22, 2020: Michigan Attorney General Dana Nessel joined 19 other attorneys general in submitting comments to the U.S. Department of Health and Human Services’ Food and Drug Administration (FDA) supporting...

FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer

On April 22, 2020, "The Food and Drug Administration granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for adult patients with metastatic triple-negative...

Johnson & Johnson and AbbVie Receives 11th FDA Approval for IMBRUVICA® (ibrutinib)

April 21, 2020: " AbbVie, a research-based global biopharmaceutical company announced that the U.S. Food and Drug Administration (FDA) approved the use of...
- Advertisment -

Most Read